₹32.72
+₹0.66 (+2.06%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹53 Cr
P/E
109.17
ROE
12.92%
ROCE
14.07%
About Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals is engaged in deals in manufacturing and trading of Pharmaceuticals. Further the company also deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
Founded
1985
CEO
Ketan Shah
Employees
26
HQ
Indore, Madhya Pradesh
About Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals is engaged in deals in manufacturing and trading of Pharmaceuticals. Further the company also deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
Founded:1985
CEO:Ketan Shah
Employees:26
HQ:Indore, Madhya Pradesh
Finished Products
1Sale of Traded Goods
₹59.42Cr2Sale of Manufactured Goods
₹14.01CrRaw Materials
1Traded goods purchased
₹26.32Cr2Raw Material Consumed
₹5.31CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹46
52W Low
₹26
Volume368.17K
Avg VolumeN/A
Beta0.82
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
109.17x
Valuation
P/B Ratio
2.47x
Valuation
EPS
₹0.30
Valuation
Dividend Yield
0.00%
Valuation
ROE
12.92%
Profitability
ROCE
14.07%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharma
-4.3%79.8%
₹26.66 Cr
Chemicals
-44.6%20.2%
₹6.742 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.14x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.